Skip to main content
M1 Kliniken AG logo

M1 Kliniken AG — Investor Relations & Filings

Ticker · M12 ISIN · DE000A0STSQ8 LEI · 529900W697S31A26WT02 F Human health and social work activities
Filings indexed 162 across all filing types
Latest filing 2026-04-22 Earnings Release
Country DE Germany
Listing F M12

M1 Kliniken AG is a provider of health services in the beauty sector, specializing in aesthetic medicine and plastic surgery. The company operates a chain of specialized medical centers offering a range of treatments, including non-surgical procedures like wrinkle and lip treatments, as well as surgical interventions such as breast corrections. The core of its business model is to provide affordable access to aesthetic treatments while maintaining high quality standards. In addition to its clinical services, the company also offers a portfolio of beauty products.

Recent filings

Filing Released Lang Actions
M1 Kliniken AG publishes preliminary figures for the 2025 financial year: strong growth in EBIT (+29%) and earnings per share (+40%)
Earnings Release Classification · 1% confidence The document is a corporate news release providing preliminary IFRS consolidated figures for the full 2025 financial year, highlighting key metrics (revenue, EBITDA, EBIT, EPS) and outlook, but does not constitute the full annual report itself. This matches the definition of an Earnings Release (ER) as an initial announcement of periodical financial results (key highlights only). FY 2025
2026-04-22 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 1% confidence The document is a comprehensive annual report for M1 Kliniken AG for the fiscal year 2024. It includes the 'Bericht des Aufsichtsrates' (Supervisory Board Report), the 'Konzernlagebericht' (Group Management Report), and detailed sections on business segments, economic conditions, and financial performance. It is clearly the full annual report rather than an announcement or a summary, as it contains substantive financial and operational analysis. FY 2024
2026-02-05 German
M1 Kliniken AG: Completion of the Sale of 100% Subsidiary HAEMATO Pharm GmbH to PHOENIX group
M&A Activity Classification · 1% confidence The document is a corporate news announcement regarding the completion of a divestiture (the sale of a subsidiary, HAEMATO Pharm GmbH). This falls under M&A activity as it describes a completed transaction involving the disposal of a business unit. While it is a corporate news release, the specific content relates to a merger/acquisition/disposal event, making 'TAR' the most accurate classification.
2026-02-02 English
Expansion of the Management Board of M1 Kliniken AG
Board/Management Information Classification · 1% confidence The document is a corporate news announcement regarding the appointment of a new member to the Management Board of M1 Kliniken AG. It explicitly mentions the expansion of the board and the appointment of Ms. Katharina Zimmnau. This falls directly under the category of board or management changes.
2025-12-11 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Audit Report / Information Classification · 1% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for M1 Kliniken AG for the fiscal year 2024. It contains a balance sheet (Bilanz), an appendix (Anhang) with accounting policies, and notes on financial items. While it is a standalone financial report, it is not the full 'Annual Report' (10-K) which typically includes a management report (Lagebericht) and auditor's opinion in a single comprehensive package. In the context of German corporate filings, this is a statutory financial statement filing. Given the options provided, 'FS' (Fund Information/Factsheet) is not appropriate, and 'IR' (Interim/Quarterly) is incorrect as this is a full-year statement. Therefore, it is best classified as an 'AR' (Audit Report/Information) as it represents the core financial reporting data and accounting disclosures required by law. FY 2024
2025-12-09 German
M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
Earnings Release Classification · 1% confidence The document is a corporate news release announcing the 9-month financial results for M1 Kliniken AG. It provides key financial highlights (revenue, EBIT, EPS) and business segment performance. It is a short, summary-style announcement (under 5,000 characters of core content) disseminated via a news service (EQS Group), which fits the definition of an Earnings Release (ER) as it provides the initial highlights of the period's performance rather than the full, comprehensive interim report. 9M 2025
2025-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.